Skip to content
PubMed This is a summary of 38 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 38 referenced papers

Top Authors

Haopeng Sun
China Pharmaceutical University
Oksana Lockridge
University of America
Patrick Masson
Service de Santé des Armées
Shuaishuai Xing
China Pharmaceutical University
Stanislav Gobec
University of Ljubljana
Qi Li
China Pharmaceutical University
Jacek Jasiecki
Gdańsk Medical University
Thomas A. Blake
National Center for Environmental Health
Chang‐Guo Zhan
University of Kentucky

Top Institutions

Ranked by publications Top 10 institutions
01

China Pharmaceutical University

Nanjing, China

21 papers
10

Institut de Médecine Tropicale du Service de Santé des Armées

Marseille, France

16 papers

References

References (38)
  1. 1

    Premature awakening and underuse of neuromuscular monitoring in a registry of patients with butyrylcholinesterase deficiency.

    Thomsen JL, Nielsen CV, Palmqvist DF, Gätke MR

    British journal of anaesthesia 2015; (115 Suppl 1()):i89-i94 doi:10.1093/bja/aev103.

    PMID: 26174307
  2. 2

    New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter.

    Jońca J, Żuk M, Wasąg B, et al.

    PloS one 2015; (10(10)):e0139480 doi:10.1371/journal.pone.0139480.

    PMID: 26444431
  3. 3

    Human butyrylcholinesterase polymorphism: Molecular modeling.

    Lushchekina S, Delacour H, Lockridge O, Masson P

    The International journal of risk & safety in medicine 2015; (27 Suppl 1()):S80-1 doi:10.3233/JRS-150699.

    PMID: 26639724
  4. 4

    [Prolonged neuromuscular block in a patient with butyrylcholinesterase deficiency].

    Mabboux I, Hary B, Courcelle S, et al.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2016; (23(5)):497-500.

    PMID: 27017361
  5. 5

    Butyrylcholinesterase deficiency.

    Delacour H, Dedome E, Courcelle S, et al.

    Annales de biologie clinique 2016; (74(3)):279-85 doi:10.1684/abc.2016.1141.

    PMID: 27237801
  6. 6

    A Case of Pseudocholinesterase Deficiency Resulting From Malnutrition.

    LaRocca CJ, Beilman GJ, Birch M

    A & A case reports 2016; (7(5)):112-4 doi:10.1213/XAA.0000000000000362.

    PMID: 27467903
  7. 7

    Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.

    Lockridge O, Norgren RB, Johnson RC, Blake TA

    Chemical research in toxicology 2016; (29(9)):1381-92 doi:10.1021/acs.chemrestox.6b00228.

    PMID: 27551784
  8. 8

    Delayed recovery from paralysis associated with plasma cholinesterase deficiency.

    Zhou W, Lv S

    SpringerPlus 2016; (5(1)):1887 doi:10.1186/s40064-016-3561-y.

    PMID: 27843744
  9. 9

    Resequencing array for gene variant detection in malignant hyperthermia and butyrylcholinestherase deficiency.

    Levano S, Gonzalez A, Singer M, et al.

    Neuromuscular disorders : NMD 2017; (27(5)):492-499 doi:10.1016/j.nmd.2017.02.008.

    PMID: 28259615
  10. 10

    Comparison between succinylcholine and rocuronium as neuromuscular blocking agents for electroconvulsive therapy in a patient with pseudocholinesterase deficiency.

    Takazawa T, Suto T, Aihara M, et al.

    JA clinical reports 2015; (1(1)):7 doi:10.1186/s40981-015-0009-2.

    PMID: 29497639
  11. 11

    Molecular characterization and polymorphisms of butyrylcholinesterase in cynomolgus macaques.

    Uno Y, Uehara S, Mahadhi HMD, et al.

    Journal of medical primatology 2018; (47(3)):185-191 doi:10.1111/jmp.12342.

    PMID: 29573432
  12. 12

    Effects of repetitive prolonged breath-hold in elite divers on myocardial fibrosis and cerebral morphology.

    Doerner J, Eichhorn L, Luetkens JA, et al.

    European journal of radiology 2018; (103()):13-18 doi:10.1016/j.ejrad.2018.03.020.

    PMID: 29803378
  13. 13

    Prolonged neuromuscular block associated with cholinesterase deficiency.

    Zhang C, Cao H, Wan ZG, Wang J

    Medicine 2018; (97(52)):e13714 doi:10.1097/MD.0000000000013714.

    PMID: 30593143
  14. 14

    Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review.

    Andersson ML, Møller AM, Wildgaard K

    Anaesthesia 2019; (74(4)):518-528 doi:10.1111/anae.14545.

    PMID: 30600548
  15. 15

    Pseudocholinesterase Deficiency Considerations: A Case Study.

    Cornelius BW, Jacobs TM

    Anesthesia progress 2020; (67(3)):177-184 doi:10.2344/anpr-67-03-16.

    PMID: 32992329
  16. 16

    Timing of blood sampling for butyrylcholinesterase phenotyping in patients with prolonged neuromuscular block after mivacurium or suxamethonium.

    Mintjens N, Brummans R, Soetens F, et al.

    Acta anaesthesiologica Scandinavica 2021; (65(2)):182-187 doi:10.1111/aas.13718.

    PMID: 33010031
  17. 17

    Genetic Testing for BCHE Variants Identifies Patients at Risk of Prolonged Neuromuscular Blockade in Response to Succinylcholine.

    Zhu GD, Dawson E, Huskey A, et al.

    Pharmacogenomics and personalized medicine 2020; (13()):405-414 doi:10.2147/PGPM.S263741.

    PMID: 33061533
  18. 18

    Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism.

    Xing S, Li Q, Xiong B, et al.

    Medicinal research reviews 2021; (41(2)):858-901 doi:10.1002/med.21745.

    PMID: 33103262
  19. 19

    Pseudocholinesterase Deficiency - Is Succinylcholine Still Needed to Facilitate Endotracheal Intubation?

    Kurnutala LN, Rugnath N

    Cureus 2020; (12(9)):e10721 doi:10.7759/cureus.10721.

    PMID: 33150117
  20. 20

    Isolation, structural characterization and quality control strategy of an unknown process-related impurity in sugammadex sodium.

    Zhuang T, Chen Y, Xu J, et al.

    Journal of pharmaceutical and biomedical analysis 2021; (200()):114072 doi:10.1016/j.jpba.2021.114072.

    PMID: 33866296
  21. 21

    Unanticipated Profound Paralysis and Sugammadex Dosing Implications After Videoscopic Thoracic Surgery.

    McKittrick ML, Lombard FW

    Seminars in cardiothoracic and vascular anesthesia 2022; (26(1)):86-89 doi:10.1177/10892532211059885.

    PMID: 34889149
  22. 22

    A Comparison of Midazolam and Propofol for Deep Sedation in Patients with Acute Respiratory Distress Syndrome Requiring Neuromuscular Blocking Agents.

    Addison JD, Daley MJ, Curran M, Hodge EK

    Journal of pharmacy practice 2024; (37(2)):271-278 doi:10.1177/08971900221131420.

    PMID: 36189765
  23. 23

    Pseudocholinesterase deficiency in ophthalmology: a systematic review.

    Cheng T, Curley M, Barmettler A

    Orbit (Amsterdam, Netherlands) 2024; (43(3)):429-437 doi:10.1080/01676830.2023.2166083.

    PMID: 36661099
  24. 24

    Neuromuscular Blockade Monitoring: Having It but Knowing When Not to Trust It.

    Salvador S, Frada R, Campos M, Esteves S

    Cureus 2023; (15(9)):e45438 doi:10.7759/cureus.45438.

    PMID: 37859899
  25. 25

    The First-Known Case of Hereditary Heterozygous Butyrylcholinesterase Deficiency in a Patient on Dialysis.

    Tokunaga N, Shima H, Okamoto T, et al.

    Cureus 2024; (16(1)):e53153 doi:10.7759/cureus.53153.

    PMID: 38420074
  26. 26

    Suspected Pseudocholinesterase Deficiency During Left Thyroid Lobectomy and Isthmusectomy: A Case Report.

    Boleyn J, McLaury M, Wieman S

    South Dakota medicine : the journal of the South Dakota State Medical Association 2024; (77(6)):266-269.

    PMID: 39013099
  27. 27

    Early Neurophysiological Monitoring of Train of Four Assists in the Detection of Pseudocholinesterase Deficiency.

    Celis V, Gandhi S, Overzet K

    The Neurodiagnostic journal 2025; (65(1)):57-63 doi:10.1080/21646821.2024.2401641.

    PMID: 39331762
  28. 28

    A novel BCHE frameshift mutation in a Chinese woman with butyrylcholinesterase deficiency: A case report and literature review.

    Zeng J, Yang D, Dai T, et al.

    Medicine 2024; (103(40)):e39976 doi:10.1097/MD.0000000000039976.

    PMID: 39465744
  29. 29

    Prolonged Neuromuscular Blockade Following Succinylcholine Administration and the Clinical Importance of Family History: A Case Report.

    Hubbell G, Slomowitz S, Thornton I

    Cureus 2025; (17(2)):e78814 doi:10.7759/cureus.78814.

    PMID: 40078265
  30. 30

    Hereditary pseudocholinesterase deficiency in a 4-year-old girl: a case report.

    Schulze-Berge J, Pillong L, Busse B, et al.

    Journal of medical case reports 2025; (19(1)):145 doi:10.1186/s13256-025-05183-5.

    PMID: 40148900
  31. 31

    Treatment of acute organophosphate poisoning by using a cocaine hydrolase engineered from human butyrylcholinesterase.

    LeSaint JE, Hou S, Chandar NB, et al.

    Chemico-biological interactions 2025; (416()):111552 doi:10.1016/j.cbi.2025.111552.

    PMID: 40339683
  32. 32

    Hereditary Pseudocholinesterase Deficiency and Succinylcholine: Historical Perspective, Therapeutic Implications, and Future Considerations.

    Nguyen JQ, Paetznick C, Donnelly RS

    Pharmacotherapy 2025; (45(9)):600-620 doi:10.1002/phar.70048.

    PMID: 40778538
  33. 33

    Prolonged paralysis following mivacurium administration in a pediatric patient with previously undiagnosed pseudocholinesterase deficiency: a case report.

    Uzun DD, Wildenberg K, Ruping F, et al.

    BMC pediatrics 2025; (25(1)):619 doi:10.1186/s12887-025-05996-9.

    PMID: 40790181
  34. 34

    Pseudocholinesterase Deficiency Uncovered During Electroconvulsive Therapy: Implications for Psychiatric Services.

    Naik MJ, Nirale A, Bhat I, et al.

    The journal of ECT 2025; doi:10.1097/YCT.0000000000001177.

    PMID: 40953291
  35. 35

    Genetic Pseudocholinesterase Deficiency Unmasked After Succinylcholine-Rivastigmine Interaction: A Case Report.

    Ho E, Simpson B, Smith NA, Harper S

    A&A practice 2025; (19(9)):e02062 doi:10.1213/XAA.0000000000002062.

    PMID: 40985564
  36. 36

    Pseudocholinesterase Deficiency in a Patient Undergoing Electroconvulsive Therapy: A Case Report.

    Ladeira AC, Laranjeira J, Guariento L, et al.

    Cureus 2025; (17(12)):e98333 doi:10.7759/cureus.98333.

    PMID: 41487739
  37. 37

    Genotype-phenotype relationships in butyrylcholinesterase deficiency: a systematic review.

    Snak de Souza CD, Ibarra Moreno CA, Riazi S, Hopkins PM

    British journal of anaesthesia 2026; (137(2)):450-459 doi:10.1016/j.bja.2026.03.056.

    PMID: 42120224
  38. 38

    Anesthetic Management of Eosinophilic Granulomatosis with Polyangiitis: A Narrative Review with an Illustrative Case in Cardiac Surgery.

    Torre DE, Pirri C

    Journal of personalized medicine 2026; (16(5)) doi:10.3390/jpm16050241.

    PMID: 42188335